Ident. | Authors (with country if any) | Title |
---|
000037 (2021) |
Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne] | What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects. |
000065 (2021) |
Guobing Li [République populaire de Chine, États-Unis] ; Shasha Ruan [République populaire de Chine] ; Xiaolu Zhao [République populaire de Chine] ; Qi Liu [États-Unis] ; Yali Dou [États-Unis] ; Fengbiao Mao [République populaire de Chine] | Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses. |
000067 (2021) |
Manel Ben Ali [Arabie saoudite] ; Amor Hedfi [Arabie saoudite] ; Mohammed Almalki [Arabie saoudite] ; Paraskevi K. Karachle [Grèce] ; Fehmi Boufahja [Tunisie] | Toxicity of hydroxychloroquine, a potential treatment for COVID-19, on free-living marine nematodes. |
000084 (2021) |
Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis] | The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review. |
000088 (2021) |
Minas Theodore Coroneo [Australie] | The eye as the discrete but defensible portal of coronavirus infection. |
000099 (2021) |
Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada] | The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. |
000125 (2021) |
Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin Chua | Successful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report. |
000127 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
000128 (2021) |
Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud] | Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. |
000141 (2021) |
Zhi-Yuan Pan [République populaire de Chine] ; Yu-Xiao Chang [République populaire de Chine] ; Ni Han [République populaire de Chine] ; Feng-Yi Hou [République populaire de Chine] ; B J Yang Lee [République populaire de Chine] ; Fa-Chao Zhi [République populaire de Chine] ; Rui-Fu Yang [République populaire de Chine] ; Yu-Jing Bi [République populaire de Chine] | Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice. |
000160 (2021) |
Saeidreza Jamalimoghadamsiahkali [Iran] ; Besharat Zarezade [Iran] ; Sogol Koolaji [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Abolfazl Zendehdel [Iran] ; Mohammad Tabarestani [Iran] ; Ehsan Sekhavati Moghadam [Iran] ; Ladan Abbasian [Iran] ; Seyed Ali Dehghan Manshadi [Iran] ; Mohamadreza Salehi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mohsen Meidani [Iran] ; Faeze Salahshour [Iran] ; Fatemeh Jafari [Iran] ; Navid Manafi [Canada] ; Fereshteh Ghiasvand [Iran] | Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. |
000169 (2021) |
Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil] | SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? |
000172 (2021) |
Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [France, États-Unis] ; Capucine Picard [France] ; Anne Puel [France, États-Unis] ; Emmanuelle Jouanguy [France, États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [France, États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France] | SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. |
000173 (2021) |
Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [États-Unis] ; Capucine Picard ; Anne Puel [États-Unis] ; Emmanuelle Jouanguy [États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France] | SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4. |
000185 (2021) |
Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne] | Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study. |
000220 (2021) |
Mengmeng Zhao [République populaire de Chine] ; Jishou Zhang [République populaire de Chine] ; Hanli Li [République populaire de Chine] ; Zhen Luo [République populaire de Chine] ; Jing Ye [République populaire de Chine] ; Yao Xu [République populaire de Chine] ; Zhen Wang [République populaire de Chine] ; Di Ye [République populaire de Chine] ; Jianfang Liu [République populaire de Chine] ; Dan Li [République populaire de Chine] ; Menglong Wang [République populaire de Chine] ; Jun Wan [République populaire de Chine] | Recent progress of antiviral therapy for coronavirus disease 2019. |
000227 (2021) |
Iwein Gyselinck [Belgique] ; Wim Janssens [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] | Rationale for azithromycin in COVID-19: an overview of existing evidence. |
000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
000232 (2021) |
Maximilian Gro E [Allemagne] ; Natalia Ruetalo [Allemagne] ; Mirjam Layer [Allemagne] ; Dan Hu [Allemagne] ; Ramona Businger [Allemagne] ; Sascha Rheber [Allemagne] ; Christian Setz [Allemagne] ; Pia Rauch [Allemagne] ; Janina Auth [Allemagne] ; Maria Fröba [Allemagne] ; Ekkehard Brysch [Allemagne] ; Michael Schindler [Allemagne] ; Ulrich Schubert [Allemagne] | Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. |
000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
000260 (2021) |
Keisuke Kuroda [Japon] ; Cong Li [Japon] ; Kiran Dhangar [Inde] ; Manish Kumar [Inde] | Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. |